192 related articles for article (PubMed ID: 8676336)
1. 4'-O-[2-(2-fluoromalonyl)]-L-tyrosine: a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides.
Burke TR; Ye B; Akamatsu M; Ford H; Yan X; Kole HK; Wolf G; Shoelson SE; Roller PP
J Med Chem; 1996 Mar; 39(5):1021-7. PubMed ID: 8676336
[TBL] [Abstract][Full Text] [Related]
2. L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.
Ye B; Akamatsu M; Shoelson SE; Wolf G; Giorgetti-Peraldi S; Yan X; Roller PP; Burke TR
J Med Chem; 1995 Oct; 38(21):4270-5. PubMed ID: 7473554
[TBL] [Abstract][Full Text] [Related]
3. Protein-tyrosine phosphatase inhibition by a peptide containing the phosphotyrosyl mimetic, L-O-malonyltyrosine.
Kole HK; Akamatsu M; Ye B; Yan X; Barford D; Roller PP; Burke TR
Biochem Biophys Res Commun; 1995 Apr; 209(3):817-22. PubMed ID: 7537500
[TBL] [Abstract][Full Text] [Related]
4. Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase-resistant SH2 domain inhibitors.
Burke TR; Smyth MS; Otaka A; Nomizu M; Roller PP; Wolf G; Case R; Shoelson SE
Biochemistry; 1994 May; 33(21):6490-4. PubMed ID: 7515682
[TBL] [Abstract][Full Text] [Related]
5. Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp.
Burke TR; Kole HK; Roller PP
Biochem Biophys Res Commun; 1994 Oct; 204(1):129-34. PubMed ID: 7524496
[TBL] [Abstract][Full Text] [Related]
6. N-terminal carboxyl and tetrazole-containing amides as adjuvants to Grb2 SH2 domain ligand binding.
Burke TR; Yao ZJ; Gao Y; Wu JX; Zhu X; Luo JH; Guo R; Yang D
Bioorg Med Chem; 2001 Jun; 9(6):1439-45. PubMed ID: 11408162
[TBL] [Abstract][Full Text] [Related]
7. Conformationally constrained phosphotyrosyl mimetics designed as monomeric Src homology 2 domain inhibitors.
Burke TR; Barchi JJ; George C; Wolf G; Shoelson SE; Yan X
J Med Chem; 1995 Apr; 38(8):1386-96. PubMed ID: 7537333
[TBL] [Abstract][Full Text] [Related]
8. Potent inhibition of protein-tyrosine phosphatase-1B using the phosphotyrosyl mimetic fluoro-O-malonyl tyrosine (FOMT).
Roller PP; Wu L; Zhang ZY; Burke TR
Bioorg Med Chem Lett; 1998 Aug; 8(16):2149-50. PubMed ID: 9873503
[TBL] [Abstract][Full Text] [Related]
9. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors.
Burke TR; Yao ZJ; Liu DG; Voigt J; Gao Y
Biopolymers; 2001; 60(1):32-44. PubMed ID: 11376431
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for inhibition of the protein tyrosine phosphatase 1B by phosphotyrosine peptide mimetics.
Groves MR; Yao ZJ; Roller PP; Burke TR; Barford D
Biochemistry; 1998 Dec; 37(51):17773-83. PubMed ID: 9922143
[TBL] [Abstract][Full Text] [Related]
11. Why is phosphonodifluoromethyl phenylalanine a more potent inhibitory moiety than phosphonomethyl phenylalanine toward protein-tyrosine phosphatases?
Chen L; Wu L; Otaka A; Smyth MS; Roller PP; Burke TR; den Hertog J; Zhang ZY
Biochem Biophys Res Commun; 1995 Nov; 216(3):976-84. PubMed ID: 7488220
[TBL] [Abstract][Full Text] [Related]
12. Potent inhibition of protein-tyrosine phosphatase by phosphotyrosine-mimic containing cyclic peptides.
Akamatsu M; Roller PP; Chen L; Zhang ZY; Ye B; Burke TR
Bioorg Med Chem; 1997 Jan; 5(1):157-63. PubMed ID: 9043667
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands. 2. 4-(2-Malonyl)phenylalanine as a potent phosphotyrosyl mimetic.
Gao Y; Luo J; Yao ZJ; Guo R; Zou H; Kelley J; Voigt JH; Yang D; Burke TR
J Med Chem; 2000 Mar; 43(5):911-20. PubMed ID: 10715157
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands.
Yao ZJ; King CR; Cao T; Kelley J; Milne GW; Voigt JH; Burke TR
J Med Chem; 1999 Jan; 42(1):25-35. PubMed ID: 9888830
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of phosphotyrosyl mimetic 4-(phosphonodifluoromethyl)phenylalanine (F2Pmp) into signal transduction-directed peptides.
Yao ZJ; Lee K; Burke TR
Methods Mol Biol; 2005; 298():91-103. PubMed ID: 16044542
[TBL] [Abstract][Full Text] [Related]
16. Utilization of 3'-carboxy-containing tyrosine derivatives as a new class of phosphotyrosyl mimetics in the preparation of novel non-phosphorylated cyclic peptide inhibitors of the Grb2-SH2 domain.
Song YL; Tan J; Luo XM; Long YQ
Org Biomol Chem; 2006 Feb; 4(4):659-66. PubMed ID: 16467940
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of phosphonodifluoromethyl phenylalanine (F2Pmp): a useful phosphotyrosyl mimetic.
Burke TR
Curr Top Med Chem; 2006; 6(14):1465-71. PubMed ID: 16918462
[TBL] [Abstract][Full Text] [Related]
18. Macrocyclization in the design of Grb2 SH2 domain-binding ligands exhibiting high potency in whole-cell systems.
Wei CQ; Gao Y; Lee K; Guo R; Li B; Zhang M; Yang D; Burke TR
J Med Chem; 2003 Jan; 46(2):244-54. PubMed ID: 12519063
[TBL] [Abstract][Full Text] [Related]
19. New syntheses of tetrazolylmethylphenylalanine and O-malonyltyrosine as pTyr mimetics for the design of STAT3 dimerization inhibitors.
Dourlat J; Valentin B; Liu WQ; Garbay C
Bioorg Med Chem Lett; 2007 Jul; 17(14):3943-6. PubMed ID: 17509878
[TBL] [Abstract][Full Text] [Related]
20. Src homology-2 domains protect phosphotyrosyl residues against enzymatic dephosphorylation.
Brunati AM; Pinna LA; Bergantino E; Ruzzene M; Cirri P; Ramponi G; Donella-Deana A
Biochem Biophys Res Commun; 1998 Feb; 243(3):700-5. PubMed ID: 9500984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
